Studien

ASCEND

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis

ASCEND

A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/​R CLL

ASCEND

A Study of Cardiovascular Events iN Diabetes

ASCEND

Assessment of Pirfenidone to Confirm Efficacy and Safety in Idiopathic Pulmonary Fibrosis

ASCEND PLUS

A research study to test whether a treatment called oral semaglutide can protect people with type 2 diabetes from heart attacks, strokes, and other health problems

ASCEND-1

A Dose Escalation/Expansion Study of LDK378 in Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase

ASCEND-10

An open-label, multicenter, phase II study of ceritinib in patients with advanced ALK+ non-lung solid tumors and hematological malignancies

ASCEND-2

A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment

ASCEND-3

LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer

ASCEND-4

LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer

ASCEND-5

LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer

ASCEND-7

A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges

ASCEND-8

LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer

ASCEND-9

LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib

ASCEND-D

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis

ASCEND-HF

Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure

ASCEND-ID

Anemia Studies in Chronic kidney disease (CKD): Erythropoiesis via a Novel prolyl hydroxylase inhibitor (PHI) Daprodustat-in Incident Dialysis

ASCEND-ND

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis

ASCEND-NHQ

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life

ASCEND-TD

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis

ASCENT

A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer

ASCENT

ACS Stent Clinical Equivalence in de Novo lesions Trial

ASCENT

Altitude Sickness in Climbers and Efficacy of NSAIDs Trial

ASCENT

Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer Triple-Negative Breast Cancer

ASCENT COPD

Aclidinium Bromide on Long-Term Cardiovascular Safety and COPD Exacerbations in PatieNTs with Moderate to Very Severe COPD

ASCERT

Society of Thoracic Surgeons Adult Cardiac Surgery Database

ASCERTAIN

Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients

ASCERTAIN

Study of ASTX727 vs IV Decitabine in MDS, CMML, and AML

ASCET

ASpirin nonresponsiveness and Clopidogrel Endpoint Trial

ASCLEPIOS

Assessment of Sirolimus- vs. paCLitaxEl-coated balloon angioPlasty In atherosclerotic femoropopliteal lesiOnS

ASCLEPIOS

Occupational Hazards to Male Reproductive Capacity: A European Concerted Action

ASCLEPIOS I

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis

ASCLEPIOS II

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis

ASCOT

Anglo-Scandinavian Cardiac Outcomes Trial (1)

ASCOT

Anglo-Scandinavian Cardiac Outcomes Trial (2)

ASCOT

Assessment of Stomach and oesophageal Cancer Outcomes from Treatment

ASCOT

Australasian COVID-19 Trial to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection

Ascot Legacy

Anglo-Scandinavian Cardiovascular Outcomes Trial Lagacy

ASCOT-BPLA

Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm

ASCOT-LLA

Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm

ASCOT1

Anglo-Scandinavian Cardiac Outcomes Trial1

ASCUS-LSIL

Atypical Squamous Cells of Undetermined Significance-Low grade Sqamous Intraepithelial Lesion triage study

ASD

Arbeitsgemeinschaft Strukturierte Diabetestherapie

ASDIAB

ASians with young-onset DIABetes

ASET

Acetyl Salicylic Elimination Trial

ASET

Acetyl Salicylic Elimination Trial Japan

ASFAST

AtheroSclerosis and Folic Acid Supplementation Trial in chronic renal failure

ASH

Arbeitsgruppe Schlaganfall Hessen

ASi in CKD

A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease

ASIAD

Abciximab in Stenting Inhibits restenosis Among Diabetics trial

ASIAN-HF

ASIAN HF Registry, A Prospective Observational Study

ASIS

Angina and Silent Ischemia Study

ASIS-1

American Study of Infarct Survival-1

ASIST

Atenolol Silent ISchemia Trial

ASK

Advancing Survivors Knowledge

ASK

Australian StreptoKinase trial in stroke

ASK

Autoimmunity Screening for Kids

Asklepios

Systemic telomere length and preclinical atherosclerosis

ASOCIA

Effect of doxazosin gastrointestinal therapeutic system on patients with uncontrolled hypertension

ASOCT

Comparison of new motorized injector vs manual injector for implantation of foldable intraocular lenses on wound integrity